BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
1 – 10 of 2590
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
- The impact of the glucagon-like peptide 1 receptor agonist liraglutide on the streptozotocin-induced diabetic mouse kidney proteome
- The effect of the mTOR inhibitor rapamycin on glucoCEST signal in a preclinical model of glioblastoma
- A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer
- Searching for the neurite density with diffusion MRI : Challenges for biophysical modeling
- Mutation patterns in a population-based non-small cell lung cancer cohort and prognostic impact of concomitant mutations in KRAS and TP53 or STK11
- Genome-wide association study of germline variants and breast cancer-specific mortality
- Pro-metastatic functions of lipoproteins and extracellular vesicles in the acidic tumor microenvironment
- Extracellular and intracellular small-molecule galectin-3 inhibitors
- EGLN2 DNA methylation and expression interact with HIF1A to affect survival of early-stage NSCLC
- Substituted polyfluoroaryl interactions with an arginine side chain in galectin-3 are governed by steric-, desolvation and electronic conjugation effects